Best Practices

Development and Implementation of a Veterans’ Cancer Survivorship Program

Author and Disclosure Information

 

References

The following recommendations should be considered for the successful implementation of a new survivorship program:

  1. Collect information from multiple resources to guide the establishment of the survivorship clinic;
  2. Become familiar with the IOM From Cancer Patient to Cancer Survivor: Lost in Transition; 6
  3. Understand local issues and barriers specific to your care delivery system;
  4. Collaborate with key stakeholders from multiple specialties to gain momentum and buy-in;
  5. Hold regular meetings with stakeholders as well as leadership to identify and remove barriers to the clinic success;
  6. Join the VA Survivorship SIG to collaborate with other sites who have already started to pilot survivorship programs and discuss barriers to and successes of programs so as to not reinvent the wheel;
  7. Utilize the Cancer Survivorship Toolkit;
  8. Download the SCP;
  9. Establish a close partnership with your local cancer committee; and
  10. Collect and report data to show effectiveness and need.

All these strategies were vital to the success of the LSCVAMC survivorship program.

Summary

The VA is uniquely positioned to be a leader in highquality, comprehensive, and veteran-centered cancer survivorship care in the years ahead. The close relationship between specialty and primary care allows for smooth continuity of care and easy transitions between oncology and primary care. The comprehensive CPRS allows easy accessibility to information for the entire health care team. The Cancer Survivorship Toolkit provides a template of the survivorship care plan for the veteran and his or her health care providers.

The LSCVAMC is one of many VA institutions implementing quality care for cancer survivors and can serve as a role model for other VA programs initiating the survivorship care process (Table 2).

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Click here to read the digital edition

Pages

Recommended Reading

MAVERIC Precision Oncology Program
Federal Practitioner
The Cost of Oncology Drugs: A Pharmacy Perspective, Part I
Federal Practitioner
Robotic Surgery for Older Cancer Patients
Federal Practitioner
A Patient Navigation Model for Veterans Traveling for Cancer Care
Federal Practitioner
Implementation of a Precision Oncology Program as an Exemplar of a Learning Health Care System in the VA
Federal Practitioner
Integrating Palliative Care and Oncology Care for Veterans With Cancer
Federal Practitioner
How Can VA Optimize Palliative Oncology Care? The AVAHO Palliative Care Research Subcommittee Is Laying the Groundwork for Productive Collaboration
Federal Practitioner
Defining Quality Cancer Survivorship Care: Symptom Burden and Distress in Veteran Cancer Survivors. VA Puget Sound Cancer Survivorship Clinic
Federal Practitioner
Change in end-of-life cancer care imperative
Federal Practitioner
HHS Buys Growth Factor Products for Emergency Use
Federal Practitioner